SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-032274
Filing Date
2024-02-12
Accepted
2024-02-12 17:16:05
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d762450ds3.htm S-3 368737
2 EX-5.1 d762450dex51.htm EX-5.1 23193
3 EX-23.1 d762450dex231.htm EX-23.1 1879
4 EX-FILING FEES d762450dexfilingfees.htm EX-FILING FEES 63360
5 GRAPHIC g762450g00g04.jpg GRAPHIC 46152
6 GRAPHIC g762450g00g18.jpg GRAPHIC 40454
7 GRAPHIC g762450g00g20.jpg GRAPHIC 37427
8 GRAPHIC g762450g0202184902204.jpg GRAPHIC 3252
9 GRAPHIC g762450g0202184902320.jpg GRAPHIC 1414
  Complete submission text file 0001193125-24-032274.txt   636478
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277018 | Film No.: 24621267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)